|
Market Closed -
Nasdaq
23:00:00 20/08/2026 +03
|
After hours 00:38:34 | |||
| 0.2126 USD | +10.16% |
|
0.2140 | +0.66% |
| Market Cap | 10.99M 9.41M 8.78M 8.06M 15.14M 1.05B 15.44M 104M 40.62M 527M 41.28M 40.38M 1.75B | P/E 2026 * |
-0.92x | P/E 2027 * | 2.76x |
|---|---|---|---|---|---|
| Enterprise Value | 10.99M 9.41M 8.78M 8.06M 15.14M 1.05B 15.44M 104M 40.62M 527M 41.28M 40.38M 1.75B | EV / Sales 2026 * |
0.14x | EV / Sales 2027 * | 0.1x |
| Free-Float |
78.25% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +10.88% | ||
| 1 week | +2.66% | ||
| Current month | -1.39% | ||
| 1 month | -9.45% | ||
| 3 months | -24.74% | ||
| 6 months | -43.50% | ||
| Current year | -57.31% |
| 1 week | 0.18 |  | 0.22 |
| 1 month | 0.18 | | 0.25 |
| Current year | 0.16 | | 0.59 |
| 1 year | 0.16 | | 1.32 |
| 3 years | 0.16 | | 2.05 |
| 5 years | 0.16 | | 150 |
| 10 years | 0.16 | | 312.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Grigorios Siokas
CEO | Chief Executive Officer | 60 | 26/02/2016 |
Georgios Terzis
DFI | Director of Finance/CFO | 43 | 11/11/2020 |
| Chief Operating Officer | 56 | 01/02/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 58 | 13/01/2014 | |
Grigorios Siokas
CHM | Chairman | 60 | 26/02/2016 |
John Hoidas
BRD | Director/Board Member | 59 | 18/11/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/30/26 A | Buy | Chief Executive Officer | 349,825 | 0.5635% | ||
| 7/29/26 A | Free | Chief Financial Officer | 328,407 | 0.5290% | ||
| 7/29/26 A | Buy | Chief Executive Officer | 766,284 | 1.2344% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +10.16% | +2.66% | -74.39% | -84.37% | 10.99M | |
| -1.75% | -4.55% | +23.91% | +99.50% | 99.53B | |
| -2.72% | -2.43% | +53.31% | +166.12% | 54.62B | |
| 0.00% | -2.03% | +2.47% | +279.08% | 23.75B | |
| +1.77% | +0.60% | -11.90% | -13.45% | 8.13B | |
| +4.98% | +1.42% | -34.86% | -20.49% | 7.42B | |
| -0.96% | -1.01% | -15.75% | -21.79% | 6.66B | |
| -4.19% | -2.40% | +5.39% | +16.10% | 6.55B | |
| +2.35% | +2.80% | -1.78% | +19.42% | 5.03B | |
| +0.56% | +3.38% | +8.29% | +18.74% | 3.71B | |
| Average | +1.19% | -0.52% | -4.53% | +45.89% | 21.54B | |
| Weighted average by Cap. | -1.32% | -1.31% | +22.96% | +118.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 80.8M 69.18M 64.55M 59.23M 111M 7.73B 113M 766M 298M 3.87B 303M 297M 12.83B | 111M 94.87M 88.51M 81.22M 153M 10.6B 156M 1.05B 409M 5.31B 416M 407M 17.59B |
| Net income | - | - |
| Net Debt | - | - |
Employees
163
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/08/26 | $0.2126 | +10.16% | 4,223,515 |
| 19/08/26 | $0.1930 | -6.58% | 4,692,644 |
| 18/08/26 | $0.2066 | +0.78% | 2,722,057 |
| 17/08/26 | $0.2050 | -5.92% | 1,640,747 |
| 14/08/26 | $0.2179 | +5.52% | 953,969 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COSM Stock
Select your edition
All financial news and data tailored to specific country editions
